Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma, IDH-wildtype · Metformin · Malignancies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
Contact: Study coordinator (Manuela Caroli, MD) · manuela.caroli@policlinico.mi.it · 0255035502

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Glioblastoma, IDH-wildtype

Abroad (travel likely)RecruitingPHASE2

Suresnes, France · Bron, France

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Recurrent Glioblastoma, IDH-Wildtype · Recurrent MGMT-Methylated Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Duarte, United States

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Anaplastic Oligodendroglioma · Astrocytoma, IDH-Mutant, Grade 3 · Astrocytoma, IDH-Mutant, Grade 4

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rochester, United States